SPPAM
TMDX icon

Summit Partners Public Asset Management’s Transmedics TMDX Stock Holding History

Summit Partners Public Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-130,000
Closed -$9.84M – 173
2023
Q1 		$9.84M Buy
+130,000
New +$8.99M 0.41% 74
2022
Q4 		– Sell
-270,000
Closed -$11.3M – 136
2022
Q3 		$11.3M Buy
+270,000
New +$11.7M 0.58% 56

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Partners Public Asset Management's TMDX Position: Q4 2024 in Review

Summit Partners Public Asset Management sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 20,347 shares — an estimated $3.19M sold.

Summit Partners Public Asset Management first reported a position in TMDX in Q2 2022 and held it in 6 quarters. The position peaked at $68.6M in Q1 2023. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Summit Partners Public Asset Management reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 20,347 Transmedics shares in Q4 2024, an estimated $3.19M.
  • Summit Partners Public Asset Management first reported a position in Transmedics in Q2 2022 and held it in 6 quarters.
  • Summit Partners Public Asset Management's Transmedics position peaked at $68.6M in Q1 2023.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Summit Partners Public Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.